Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Costa BA, Flynn J, Nishimura N, Devlin SM, Farzana T, Rajeeve S, Chung DJ, Landau HJ, Lahoud OB, Scordo M, Shah GL, Hassoun H, Maclachlan K, Hultcrantz M, Korde N, Lesokhin AM, Shah UA, Tan CR, Giralt SA, Usmani SZ, Nath K, Mailankody S.
Costa BA, et al. Among authors: tan cr.
Blood Cancer J. 2024 May 27;14(1):84. doi: 10.1038/s41408-024-01048-0.
Blood Cancer J. 2024.
PMID: 38802346